New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
May 8, 2014
07:26 EDTLCILannett shares should be bought on weakness, says Oppenheimer
After Lannett reduced its Q4 guidance but provided higher than expected FY15 revenue guidance based on price increases it has implemented, Oppenheimer believes that investors should be pleased with the overall guidance. The firm keeps a $49 price target and Outperform rating on the stock.
News For LCI From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
October 8, 2014
06:47 EDTLCILawmakers may push for new regulations on generic drug makers, NY Times says
After the prices of some generic drugs soared more than 1,000% over the last year, two influential members of Congress are probing the sector and threatening to look to impose new regulations on it, according to The New York Times. Generic drug makers include Teva (TEVA), Mylan (MYL), Actavis (ACT), and Lannett (LCI).Reference Link

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use